Organon market cap
WitrynaOGN: Get the latest Organon & Company stock price and detailed information including OGN news, historical charts and realtime prices. ... Market Cap. 254.38 M Number of … WitrynaThe market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth. Market cap history of Hualan Biological Engineering from 2004 to 2024. End of year Market Cap. Year Market cap Change; 2024: $6.01 B: …
Organon market cap
Did you know?
Witryna5 kwi 2024 · Organon & Co. has a market cap or net worth of $6.01 billion as of April 6, 2024. Its market cap has decreased by -32.57% in one year. Market Cap 6.01B. … Witryna17 sie 2024 · Organon. The guru disclosed a 1.55 million-share investment in Organon ... The New Jersey-based pharmaceutical company, which was spun off of Merck in June, has an $8.7 billion market cap; its ...
WitrynaAs of April 2024 Organon has a market cap of $6.04 Billion . This makes Organon the world's 2096th most valuable company by market cap according to our data. The … Witryna14 kwi 2024 · The company has a market capitalization of $6.10 billion, a price-to-earnings ratio of 6.68, a price-to-earnings-growth ratio of 0.99 and a beta of 0.76. Organon & Co. has a 52-week low of $20.96 ...
Witryna2 dni temu · Detailed statistics for Organon & Co. (OGN) stock, including valuation metrics, financial numbers, share information and more. ... Organon & Co. has a … Witryna28 lut 2024 · Key failure to deliver metrics for Organon: Last SEC data release: 2024-02-28. Last 15 days FTD volume: $0.53 M. Last 3 months FTD volume: $4.3 M. Last year FTD volume: $19.92 M. A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
WitrynaThe Organon & Co PE ratio based on its reported earnings over the past 12 months is 6.28. The shares last closed at $29.94. The PE ratio (or price-to-earnings ratio) is the …
Witryna6 kwi 2024 · The main competitors of Organon & Co. include Roivant Sciences (ROIV), Karuna Therapeutics (KRTX), Ascendis Pharma A/S (ASND), Prometheus Biosciences (RXDX), Ionis Pharmaceuticals (IONS), Perrigo (PRGO), Grifols (GRFS), Elanco Animal Health (ELAN), Legend Biotech (LEGN), and Intra-Cellular Therapies (ITCI). These … binance for texasWitrynaThe Organon & Co PE ratio based on its reported earnings over the past 12 months is 6.28. The shares last closed at $29.94. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share. binance for dummiesWitryna2 cze 2024 · Calculating Organon’s Market Value. ... This is calculated by adding $5.635 billion in debt less $1 billion in cash on hand to the $9 billion pro forma market cap. As a result, the pro forma EV ... binance for united statesWitryna11 kwi 2024 · 99,9%. More Financials. Company. Organon & Co. specializes in the development, manufacture and marketing of pharmaceutical products for women's … binance foxWitrynaOrganon market cap history and chart from 2024 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly … binance for laptopWitryna11 kwi 2024 · Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and … binance freeze accountWitryna11 kwi 2024 · OGN stock opened at $23.85 on Tuesday. The company has a market cap of $6.07 billion, a PE ratio of 6.64, a price-to-earnings-growth ratio of 0.99 and a beta of 0.77. The stock has a 50-day moving average price of $25.07 and a two-hundred day moving average price of $26.08. Organon & Co. has a 12-month low of $20.96 and a … cypher pool 0